Heartbeam Inc — Quarterly Financial Statistics (NASDAQ:BEAT) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 3.31 M4.15 M4.48 M3.44 M3.16 M 15.23 M Cash from investing activities 103 K03.76 M-1.86 M-1.72 M 184 K Cash from financing activities 21 K761 K10.25 M450 K45 K 11.51 M Free cash flow 3.2 M4.15 M4.48 M3.34 M3.08 M 15.05 M

뉴스

하트빔, 브라이언 험버거 최고 상업 책임자 임명

HeartBeam appoints Bryan Humbarger as chief commercial officer

빔 테라퓨틱스, AATD 프로그램 전망에 목표주가 상향

Bernstein raises Beam Therapeutics stock price target to $37 on AATD program outlook

UBS, 빔 테라퓨틱스에 ’중립’ 등급 제시

Beam Therapeutics stock initiated with Neutral rating by UBS

하트빔 주가 급등, H.C. Wainwright 목표가 두 배로 상향

HeartBeam stock soars as H.C. Wainwright doubles price target on FDA clearance

BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System

수요일 주목받은 주식: 오라클, 시높시스, 하트빔, 플래닛 랩스 및 어도비

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.05%

Oracle, Synopsys, Heartbeam, Planet Labs And Adobe: Why These 5 Stocks Are On Investors' Radars Today - Adobe (NASDAQ:ADBE), HeartBeam (NASDAQ:BEAT)